Quantcast
Last updated on June 19, 2013 at 12:49 EDT

Latest Breast cancer Stories

2013-05-02 16:28:53

Product Revenue Increased 8% Compared to Prior Year REDWOOD CITY, Calif., May 2, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today reported financial results and business progress for the quarter ended March 31, 2013. (Logo: http://photos.prnewswire.com/prnh/20130425/SF01493LOGO) Total revenue for the first quarter of 2013 increased to $63.1 million, compared with $58.5 million in the first quarter of 2012. Product revenue was $62.7 million in the first...

2013-05-02 12:29:14

Shop with your mothers, daughters and friends May 4 through May 6 and give back! NEW YORK, May 2, 2013 /PRNewswire/ -- Ann Taylor is proud to support The Breast Cancer Research Foundation® (BCRF) through the sale of the Ann Taylor Cares Card at Ann Taylor stores nationwide during the month of May. In addition, a set of three shades of pink nail polish will be available for purchase. 90% of the purchase price of the Ann Taylor Cares Card and 50% of the purchase price of the nail...

2013-05-02 12:29:02

Revenues Continue to Ramp in 2013 IRVINE, Calif., May 2, 2013 /PRNewswire/ -- Agendia, a world leader in molecular cancer diagnostics, today announced that it has reported more than 20,000 MammaPrint breast cancer results, including approximately 6,000 in 2012 alone. The MammaPrint test analyzes 70 key genes and accurately determines which patients are at low risk of breast cancer recurrence and can therefore safely choose not to undergo chemotherapy. Case volume grew by more than...

2013-05-02 08:39:01

GARDEN CITY, N.Y., May 2, 2013 /PRNewswire/ -- Millennium HealthCare Inc. (OTC Pink: MHCC) today announced that its Medical Device subsidiary signed an agreement with Atossa Genetics Inc. (NASDAQ: ATOS) for the distribution of Atossa's ForeCYTE Breast Health devices, which consist of the patented MASCT pump and ForeCYTE patient collection kits. Millennium has submitted an initial order for 10,000 ForeCYTE collection kits, which it intends to market to managed-care networks,...

2013-05-02 08:37:18

Accurate, Rapid, Cost-Effective Blood Test Aims to Confirm True Negative Findings While Halving the Rate of False Negative Mammography Results MIAMI, May 2, 2013 /PRNewswire/ -- Eventus Diagnostics, Inc. (EventusDx) today announced that it has received CE mark designation for its Octava Pink(TM) breast cancer test intended for confirmatory use in women who have received negative mammography results. The National Cancer Institute (NCI) estimates that screening mammograms miss about...

2013-05-02 08:37:08

STOCKHOLM, May 2, 2013 /PRNewswire/ -- Karolinska Institutet and University Hospital have shown that a simple blood test can predict breast cancer patients response to therapy, how long treatment will be effective and survival. The results are being presented at the IMPAKT scientific conference in Brussels, May 2-4. The analysis measures growth rate and this is the first time ever that one test have documented this by analysing a blood sample. (Photo:...

Genomics Help Improve Endometrial Cancer Treatment
2013-05-02 07:54:13

redOrbit Staff & Wire Reports - Your Universe Online Adding genomics-based testing to standard patient evaluation process could drastically alter the recommended treatment program for women with endometrial cancer, as well as the classification of that form of cancerous tumor, claims research published Thursday in the journal Nature. As part of the study, investigators from The Cancer Genome Atlas (TCGA) Research Network analyzed endometrial cancer tumor samples from 373 patients...

2013-05-01 16:30:36

Complete Results from UCSF-Led Validation Study to be Presented Earlier that Day at the American Urological Association (AUA) Annual Meeting in San Diego REDWOOD CITY,Calif., May 1, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that it will host an investor webcast and conference call to discuss the positive development and clinical validation study results of its biopsy-based Oncotype DX prostate cancer test on Wednesday, May 8, 2013 at...

2013-05-01 16:29:05

Amgen's Breakaway from Cancer to Celebrate Cancer Survivors at Every Stage of the Eighth Annual Professional Cycling Race THOUSAND OAKS, Calif., May 1, 2013 /PRNewswire/ -- Amgen today announced that four individuals who are an inspiration and have made a difference for others affected by cancer have been selected as Breakaway from Cancer(®) Champions. They will be honored as part of Amgen's Breakaway from Cancer initiative at the eighth consecutive edition of the Amgen Tour of...

2013-05-01 16:27:42

American Cancer Society to Mark 100(th) Birthday on May 22 NEW YORK, May 1, 2013 /PRNewswire-USNewswire/ -- This May 22nd, the American Cancer Society will mark its 100th birthday and EHE International has donated a window at 10 Rockefeller Plaza to celebrate this remarkable milestone. Throughout the month of May, a 115-square foot display window at 10 Rockefeller Plaza will showcase a "life list" of NBC TODAY Show host and breast cancer survivor Hoda Kotb. Some of the major...


Latest Breast cancer Reference Libraries

Clinical Breast Cancer
2012-06-04 20:06:33

Clinical Breast Cancer is a peer-reviewed medical journal established in 2000 and published bimonthly by Elsevier. As of May 2012, the editor-in-chief is George W. Sledge, Jr. The journal publishes original articles describing various aspects of clinical and translational research of breast cancer. It is devoted to articles on detection, diagnosis, prevention, and treatment of breast cancer. The main emphasis is on recent scientific developments in all areas related to breast cancer....

Breast Cancer Research and Treatment
2012-05-07 07:48:55

Breast Cancer Research and Treatment is a peer-reviewed scientific journal published by Springer Verlag. It focuses on the treatment of and investigations in breast cancer. The journal is targeted towards a wide audience of clinical researchers, epidemiologists, immunologists, and cell biologists whom are interested in breast cancer. Articles in this journal include: original research, invited reviews, discussions on controversial issues, book reviews, meeting reports, letters to the editors,...

More Articles (2 articles) »